Evidence map›Paper›PMID 42697414›Full record

ArticleThe Journal of biological chemistry2026

The black fly salivary protein Simukunin inhibits complement activation through the lectin pathway protease MASP-2.

Michelle D Jung, Molly E Ring, Brian Gabriel Bonilla, Sundar Ganesan, Paola Carolina Valenzuela-Leon, Eric Calvo

Abstract read
In one paragraph

Article in The Journal of biological chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Michelle D JungLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Molly E RingLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Brian Gabriel BonillaLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA.
Sundar GanesanBiological Imaging Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Paola Carolina Valenzuela-LeonLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA. Electronic address: valenzuelaleop@nih.gov.
Eric CalvoLaboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, Maryland, USA. Electronic address: ecalvo@niaid.nih.gov.

Funding

NIAID NIH HHS HHSN272201700035INIAID NIH HHS HHSN272201700051INIH HHS 75N93024F00002
6 · The paper itself

Abstract

Salivary secretions from blood-feeding arthropods are enriched with bioactive molecules that counteract host hemostatic and immune defenses, including blood coagulation, platelet aggregation, complement activation, and vasoconstriction. Although numerous salivary components have been identified and functionally characterized across hematophagous arthropods, their specific roles in complement inhibition in black flies remain insufficiently defined. Previously, it was discovered that Simukunin, a salivary protein from Simulium vittatum, inhibits procoagulant activity. Here, using surface plasmon resonance and enzymatic assays, we found that Simukunin also acts as a specific inhibitor of the complement lectin pathway (LP). Simukunin binds with high affinity to mannose-associated serine protease 2 (MASP-2), a serine protease crucial for LP activation, preferentially blocking cleavage of C2 over C4, resulting in reduced downstream membrane attack complex deposition. No interaction with other downstream complement proteins was found. Simukunin also inhibits the procoagulant activity of MASP-2 in vitro. Notably, pretreatment with Simukunin significantly improved survival rates in a murine model of lipopolysaccharide-induced sepsis. Overall, Simukunin emerges as a novel complement inhibitor and a potential candidate for therapeutic applications.

Indexed as

arthropodsblood feedingcoagulationcomplementsalivavascular biology

Identifiers

PMID42697414
PMCPMC13656542

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.